Medical device manufacturer, Beckman Coulter Inc, has issued a medical device safety alert for the Ac•T 8/10 Series, Ac•T diff™ and Ac•T diff2™ hematology systems. The affected reagent part numbers and lot numbers are identified as follows:
The manufacturer has received an increased number of service calls and customer complaints related to the Hemoglobin (Hgb) parameter on the Ac‧T series analyzers. An investigation revealed that the issues may have been related to variability in a component of the diluents which in turn may lead to a film coating the inside of the WBC bath where the Hgb is measured. The issue is not observed with all analyzers.
The use of the diluent lots mentioned above may eventually result in a compromised WBC bath. Symptoms include:
Unexpected variations between the Hgb & Hct (Hematocrit) indicated by the asterisk (*) flag have not been reported. Test results are not affected.
The manufacturer will take actions to address Hgb issues. WBC baths are currently being replaced as needed.
All new shipments of Ac‧T reagents containing diluents are currently being manufactured with a component that does not exhibit this variability.
According to the local supplier, the affected products are distributed in Hong Kong.
If you are in possession of the affected products, please contact your supplier for necessary actions
Posted on 8 September 2015